Is a Pancreas Transplant an Option for Type 1 Diabetes?

Can You Get a Pancreas Transplant for Type 1 Diabetes?

Can You Get a Pancreas Transplant for Type 1 Diabetes?
Adobe Stock

If you have type 1 diabetes, you may have wondered if a pancreas transplant could cure your condition.

In fact, for a select group of people with advanced complications, a pancreas transplant may be an option, offering independence from insulin treatment and fewer blood sugar fluctuations. But these surgeries are extremely rare. This type of transplant is not a first-line treatment for diabetes and is generally not considered to be a cure. Eligibility requirements are strict, and post-surgery risks are significant, potentially even outweighing the downsides of life with type 1.

“Transplant is not a cure — it’s a treatment,” says Charles Bratton, MD, a transplant surgeon from Loma Linda University Health in Loma Linda, California. “The question is whether that treatment gives you a better life than the disease itself.”

Why Pancreas-Only Transplants Are So Rare

A pancreas transplant involves connecting a healthy donor pancreas to your intestines. In theory, this staves off the primary complication of type 1 diabetes: The new healthy organ can produce insulin on its own and keep blood sugar levels steady and healthy without the use of insulin injections.

This transplant may occur at the same time as a kidney transplant if you have or are approaching kidney failure.

But pancreas-alone transplants are exceptionally rare. In the United States, about 100 are performed annually.

Factors that keep the number of transplants low include:

  • Donor criteria are strict, and pancreases must come from otherwise healthy donors, usually younger than 60 years old.
  • A full pancreas must come from a person who has recently died.
  • The pancreas itself is a particularly fragile organ, Dr. Bratton says. It may be damaged when removed from the donor.
  • Transplant risks may outweigh benefits for many people with type 1 diabetes.
Transplant wait lists also are long, averaging three years.

Bratton adds that endocrinologists and primary care physicians may not know that a transplant can be a reasonable option for some patients.

“Endocrinologists know how to manage diabetes with insulin and pumps, so they don’t refer people for a transplant,” he says.

Life After a Pancreas Transplant: Benefits

The primary benefit of a pancreas transplant is insulin independence. Although not every pancreas transplant has equally good results, more than 90 percent of recipients may no longer need insulin, at least in the short term. On average, insulin independence may last about six years, though results vary widely.

This change can be so dramatic, Bratton says, that transplant recipients sometimes have a tough time trusting that their new pancreas will take over the nonstop work of blood sugar management.

“The first thing they notice right away is that they wake up and their blood sugars are perfectly normal,” Bratton says.

As a result of improved blood sugar levels, transplant recipients also usually experience a sharply reduced risk of diabetes complications like retinopathy, neuropathy, and cardiovascular disease. In some cases, the progression of complications can even reverse.

Life expectancy also may improve after a pancreas transplant, assuming there are minimal or no complications.

Life After a Pancreas Transplant: Downsides

Pancreas transplants also come with significant risks, from the surgery itself to the need for immune system suppression to protect the transplanted pancreas.

  • Surgical Risks These may include bleeding, infection, intestinal blockage, and fluid buildup, which may require more care, possibly including additional surgeries.

  • Organ Rejection About 10 to 15 percent of pancreas transplants fail within the first year.

  • Short-Term Impact About 30 percent of recipients need to use at least some insulin after three years.

  • Long-Term Transplant Risks These may include a heightened risk of infections and cardiovascular problems.

     About 43 percent of transplanted pancreases also do not last more than 10 years.

  • Medication Side Effects Antirejection medications can cause weight gain, high blood pressure, and infections.

The volume of follow-up medications can also be large, says Ali Dugger, 40, who received a pancreas transplant at age 39 at the Loma Linda University Transplant Institute in Loma Linda, California. She says she takes handfuls of pills at specific times each day to prevent her immune system from attacking the new organ.

“Nearly a year out, I’m still having my labs drawn every two weeks,” she says. “It’s not just losing your organs that can kill you. It’s the suppressed immune system — things you’ve never heard of. Raking dead leaves could land you in the hospital with a fungal infection. Swimming in a lake could make you septic. Even a vitamin with immune-boosting herbs like echinacea could send you into organ rejection.

“(The transplant) enables you to live, but it comes with even more rules than type 1 diabetes.”

Simultaneous Kidney-Pancreas Transplants

For people with type 1 diabetes who already need a kidney transplant because of kidney failure, having a pancreas transplant at the same time does not add considerable risk. Kidney recipients already must take antirejection medication just as a pancreas recipient would, and the transplants offer a chance at stopping insulin and dialysis treatments. Pancreas success rates also are higher after simultaneous transplants than in pancreas-alone transplants.

“Pancreas transplantation on top of kidney transplantation will actually improve and extend your life even further,” Bratton says. “The kidney protects the pancreas. It increases your ability to survive and reduces rejection.”

As many as 85 percent of pancreas transplants occur at the same time as kidney transplants.

 Although the transplants are most common in people with type 1 diabetes, people with type 2 diabetes also may be eligible.

The two transplants may occur at the same time or in separate procedures.

Simultaneous kidney-pancreas transplants are more common than pancreas-alone transplants, with 800 to 900 occurring in the United States annually. Recipients have about an 80-percent probability of not requiring insulin treatment or dialysis in the first year and a 70-percent chance of not needing them for five years. The one-year survival rate for the combined transplant is 97.1 percent, with 79.1 percent of recipients living at least 10 years.

Who Is Eligible for a Pancreas Transplant?

Pancreas transplants are usually only performed on people who have extreme diabetes management challenges, such as repeated bouts of diabetic ketoacidosis (DKA) or severe hypoglycemia.

Bratton says you may be eligible for a pancreas transplant if you have:

  • End-stage kidney disease caused by type 1 diabetes
  • Severe hypoglycemia unawareness, or the inability to spot symptoms of dangerously low blood sugar
  • “Brittle” diabetes, an unofficial diagnosis that refers to extreme blood sugar swings.

You may be not be eligible for a transplant if you are age 65 or older or have:

  • Heart disease
  • Significant insulin requirements
  • Obesity
  • History of excessive use of alcohol, tobacco, or drugs
  • Other restricting medical conditions, including many types of cancer and immunodeficiencies

Dugger says that she passed “tests for my heart, bladder, bones, and mental health” before her transplant and that she also needed to prove she had “two dependable caregivers” to help her with surgery recovery.

Islet Cell Transplants

An islet cell transplant is a less invasive surgery than a pancreas transplant. It involves the insertion of only the cells that produce insulin rather than a full pancreas. The Food and Drug Administration has approved this procedure to treat people with type 1 diabetes who cannot manage their blood sugar and have severe hypoglycemia.

Islet cell transplantation can dramatically improve blood sugar levels while reducing the risk of severe hypoglycemia, and about half of recipients achieve insulin independence for the first year.

The procedure has some of the same downsides as a pancreas transplant, including a need for antirejection medication and a lack of donor cells because islet cells must come from one or more deceased organ donors.

Researchers are exploring ways to grow islet cells, derived from human stem cells, in a lab, which could remove one major barrier to widespread growth of the procedure.

“Modern man-made islet cells require significantly fewer donors,” Bratton says. “It’s not perfect. But diabetes is devastating, and that’s why research continues.”

The Takeaway

  • Pancreas transplants offer a potential option for insulin independence in some people with severe complications of type 1 diabetes.
  • Although the transplants can significantly improve quality of life, the procedure carries serious risks, including the possibility of organ rejection and the need for immune-suppressing medications.
  • Only about 100 pancreas-alone transplants occur in the United States each year. Simultaneous kidney and pancreas transplants, for people with kidney disease and diabetes, are more common.
  • Alternative options like islet cell transplants may provide benefits, though this surgery is not commonly performed yet.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Pancreas Transplantation. Johns Hopkins Medicine.
  2. Kidney and Pancreas Transplant. Cleveland Clinic. August 19, 2024.
  3. Transplant: Transplant Year (2023 - 2024) by Donor Type. Organ Procurement & Transplantation Network. December 2025.
  4. Bahar SG et al. Pancreas Transplantation. StatPearls. March 14, 2023.
  5. Altabas V et al. Current Challenges in Pancreas and Islet Transplantation: A Scoping Review. Biomedicines. December 15, 2024.
  6. Giri G et al. The Impact of Pancreas Transplantation on Diabetic Complications: A Systematic Review. Transplantation Reviews. April 2025.
  7. Pancreas Transplant. Cleveland Clinic. October 26, 2022.
  8. Early Risks of a Pancreas Transplant. NHS Blood and Transplant.
  9. Rejection of a Transplanted Pancreas. NHS Blood and Transplant.
  10. Pullen LC. Remembering Pancreas Transplantation as an Option for Patients With Diabetes. American Journal of Transplantation. April 2025.
  11. Longer-Term Risks of a Pancreas Transplant. NHS Blood and Transplant.
  12. Casey MJ et al. Medical and Surgical Management of the Failed Pancreas Transplant. Transplantation Direct. December 12, 2023.
  13. Preparing for a Pancreas Transplant. University of Florida Health.
  14. Martin D et al. Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions. Journal of Clinical Medicine. May 1, 2023.
  15. Simultaneous Pancreas/Kidney Transplantation at the Penn Transplant Institute. Penn Medicine. October 23, 2025.
  16. Brittle Diabetes. Cleveland Clinic. February 6, 2024.
  17. Pancreatic Islet Transplantation. National Institute of Diabetes and Digestive and Kidney Diseases. October 2018.
  18. Krigel M. Novel Therapy Aims to Make Type 1 Diabetes Patients Insulin Free. University of California San Francisco. September 19, 2025.
Anna-L-Goldman-bio

Anna L. Goldman, MD

Medical Reviewer

Anna L. Goldman, MD, is a board-certified endocrinologist. She teaches first year medical students at Harvard Medical School and practices general endocrinology in Boston.

Dr. Goldman attended college at Wesleyan University and then completed her residency at Icahn School of Medicine at Mount Sinai Hospital in New York City, where she was also a chief resident. She moved to Boston to do her fellowship in endocrinology at Brigham and Women's Hospital. She joined the faculty after graduation and served as the associate program director for the fellowship program for a number of years.

Ginger Vieira

Author

Ginger Vieira has lived with type 1 diabetes and celiac disease since 1999, and fibromyalgia since 2014. She is the author of Pregnancy with Type 1 Diabetes, Dealing with Diabetes BurnoutEmotional Eating with Diabetesand Your Diabetes Science Experiment.

Ginger is a freelance writer and editor with a bachelor's degree in professional writing, and a background in cognitive coaching, video blogging, record-setting competitive powerlifting, personal training, Ashtanga yoga, and motivational speaking.

She lives in Vermont with a handsome husband, two daughters, and a loyal dog named Pedro.